Literature DB >> 1418008

In vivo expression of stromelysin in synovium and cartilage of rabbits injected intraarticularly with interleukin-1 beta.

N I Hutchinson1, M W Lark, K L MacNaul, C Harper, L A Hoerrner, J McDonnell, S Donatelli, V Moore, E K Bayne.   

Abstract

OBJECTIVE: To examine the in vivo expression of the matrix metalloproteinase stromelysin in the synovium and articular cartilage of rabbits injected intraarticularly with recombinant human interleukin-1 beta (IL-1).
METHODS: The direct isolation of messenger RNA (mRNA) from articular cartilage without the prior isolation of chondrocytes is described. The in vivo expression of stromelysin was examined at the mRNA level by Northern blot analysis, and at the protein level by in situ immunolocalization and by enzyme-linked immunosorbent assay.
RESULTS: In the synovium of IL-1-injected joints, stromelysin mRNA levels were highest at 4 hours and declined to background levels within 24 hours. In the cartilage of IL-1-injected joints, stromelysin mRNA was elevated at 4 hours and continued to increase until 8 hours, before declining. Stromelysin mRNA expression preceded a similar increase in stromelysin protein levels in both synovium and cartilage.
CONCLUSION: Intraarticular injection of IL-1 induced the endogenous expression of stromelysin mRNA and protein in both synovium and cartilage. The kinetics of stromelysin expression correlated well with the accumulation of stromelysin and proteoglycan in synovial fluids. Therefore, the de novo synthesis of stromelysin in cartilage may have contributed to the loss of proteoglycan from that tissue.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1418008     DOI: 10.1002/art.1780351016

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

1.  Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint.

Authors:  C M Flory; P A Pavco; T C Jarvis; M E Lesch; F E Wincott; L Beigelman; S W Hunt; D J Schrier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

2.  Decline after immobilisation and recovery after remobilisation of synovial fluid IL1, TIMP, and chondroitin sulphate levels in young beagle dogs.

Authors:  J Haapala; J P Arokoski; S Rönkkö; U Agren; V M Kosma; L S Lohmander; M Tammi; H J Helminen; I Kiviranta
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

3.  Inhibitors of collagenase but not of gelatinase reduce cartilage explant proteoglycan breakdown despite only low levels of matrix metalloproteinase activity.

Authors:  C J Brown; S Rahman; A C Morton; C L Beauchamp; H Bramwell; D J Buttle
Journal:  Clin Mol Pathol       Date:  1996-12

4.  Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis.

Authors:  S Sasaki; H Iwata; N Ishiguro; K Obata; T Miura
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

5.  VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.

Authors:  I I Singer; D W Kawka; E K Bayne; S A Donatelli; J R Weidner; H R Williams; J M Ayala; R A Mumford; M W Lark; T T Glant
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

6.  Metalloproteinase production by rabbit articular cartilage: comparison of the effects of interleukin-1 alpha in vitro and in vivo.

Authors:  R M Hembry; M R Bagga; J T Dingle; P P Thomas; J J Reynolds
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Effects of Payena dasyphylla (Miq.) on hyaluronidase enzyme activity and metalloproteinases protein expressions in interleukin-1β stimulated human chondrocytes cells.

Authors:  Kamini Citalingam; Seema Zareen; Khozirah Shaari; Syahida Ahmad
Journal:  BMC Complement Altern Med       Date:  2013-08-23       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.